The Office of Oncology Drug Products (OODP) is responsible for making safe and effective drug and therapeutic biologic treatments for cancer available to the U.S. public. OODP oversees development, approval, and regulation of: * Drug treatments for cancer * Therapeutic biologic treatments for cancer * Therapies for prevention of cancer * Drug and biologic products used for medical imaging * Products for treatment of nonmalignant hematologic conditions
BCO is a peer-reviewed educational service made available free to users working in the numerous fields of breast cancer research and treatment. The content of the website is invited and reviewed by an independent international editorial board of experts from a multi-disciplinary perspective. This site is intended for healthcare professionals and as such may contain information not intended or suitable for patients. For this reason we ask interested readers to register for usage.
Written for the nonmedical community, free online articles on the latest research news.
"All research articles published in Breast Cancer Research are open access " To read the article abstract, click on the article title. To read the entire article, click on provisional pdf." Articles noted as "free" can be read online by clicking on the article title.
Published monthly by the Johns Hopkins Breast Center, online only. Excellent source of the latest news, written in a clear understandable style.